ChEMBL logo

ChEMBL

spacer
ChEMBL Statistics
  Loading Statistics...
spacer

Compound Report Card

Compound Name and Classification

Compound ID CHEMBL1200775
CHEMBL1200775
Compound Name LEUPROLIDE ACETATE
ChEMBL Synonyms Leuprorelin | Lupron Depot PED | VIADUR | ABBOTT-43818 | ELIGARD | TAP-144 | LUPRON | Carcinil | LUPRON DEPOT | LUPRON DEPOT-PED | LEUPROLIDE ACETATE
Max Phase 4 (Approved)
Trade Names Carcinil | ELIGARD | LEUPROLIDE ACETATE | LUPRON | LUPRON DEPOT | LUPRON DEPOT-PED | Leuprorelin | Lupron Depot PED | VIADUR
Molecular Formula C61H88N16O14

Additional synonyms for CHEMBL1200775 found using NCI Chemical Identifier Resolver

Compound Representations

Molfile Download MolFile
Canonical SMILES CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C ...
Download SMILES
Standard InChI InChI=1S/C59H84N16O12.C2H4O2/c1-6-63-57(86)48-14-10-22-75(48 ...
Download InChI
Standard InChI Key RGLRXNKKBLIBQS-XNHQSDQCSA-N

Sources

  • Orange Book
  • PubChem BioAssays
  • Scientific Literature
  • USP Dictionary of USAN and International Drug Names

Alternate Forms of Compound in ChEMBL


CHEMBL1200775

Molecule Features

CHEMBL1200775 compound icon
Drug Type:Oligopeptide Rule of Five:N First In Class:N Chirality:Single Stereoisomer Prodrug:N Oral:Y Parenteral:Y Topical:N Black Box:N Availability Type:Prescription-only

Mechanism of Action

Mechanism of Action ChEMBL Target References
Gonadotropin-releasing hormone receptor agonist Gonadotropin-releasing hormone receptor FDA

Indications

MESH Heading MESH ID EFO ID EFO Term Max phase for indication References
Breast NeoplasmsD001943EFO:0000305breast carcinoma3ClinicalTrials
ClinicalTrials
Multiple MyelomaD009101EFO:0001378multiple myeloma2ClinicalTrials
Puberty, PrecociousD0116293ClinicalTrials
Breast NeoplasmsD001943EFO:0003869breast neoplasm3ClinicalTrials
HypertensionD006973EFO:0000537hypertension0ClinicalTrials
Alzheimer DiseaseD000544EFO:0000249Alzheimers disease2ClinicalTrials
NeoplasmsD009369EFO:0000311cancer3ClinicalTrials
Prostatic NeoplasmsD011471EFO:0001663prostate carcinoma3ClinicalTrials
ClinicalTrials
EndometriosisD004715EFO:0001065endometriosis2ClinicalTrials
ClinicalTrials
LeiomyomaD007889EFO:0000731uterine fibroid3ClinicalTrials
ObesityD009765EFO:0001073obesity3ClinicalTrials
ClinicalTrials
Prostatic NeoplasmsD011471EFO:0000673prostate adenocarcinoma3ClinicalTrials
ClinicalTrials
Hodgkin DiseaseD006689EFO:0000183Hodgkins lymphoma2ClinicalTrials
Lymphoma, Mantle-CellD020522EFO:1001469Mantle cell lymphoma2ClinicalTrials

Clinical Data

ClinicalTrials.gov LEUPROLIDE ACETATE
The Cochrane Collaboration LEUPROLIDE ACETATE

Compound Bioactivity Summary

Compound Assay Summary

Compound Target Summary

Calculated Compound Parent Properties

Mol. Weight Mol. Weight Monoisotopic ALogP #Rotatable Bonds Polar Surface Area Molecular Species
1209.4 1208.6455 - - - -


HBA HBD #Ro5 Violations HBA (Lipinski) HBD (Lipinski) #Ro5 Violations (Lipinski)
- - - - - -


ACD Acidic pKa ACD Basic pKa ACD LogP ACD LogD pH7.4 Aromatic Rings Heavy Atoms QED Weighted
- - - - - - -0

Structural Alerts

There are no structural alerts for CHEMBL1200775

Compound Cross References

ChemSpider ChemSpider:RGLRXNKKBLIBQS-XNHQSDQCSA-N
DailyMed leuprolide acetate
PubChem SID: 144207056

UniChem Cross References

View the UniChem Connectivity matches for CHEMBL1200775



ChEBI 63597
ChemicalBook CB7174300
EPA CompTox Dashboard DTXSID7049009
FDA SRS 37JNS02E7V
MolPort MolPort-044-727-713
PubChem 657180
PubChem: Drugs of the Future 12013727
PubChem: Thomson Pharma 14939542 14890543 14792717
SureChEMBL SCHEMBL3174

UniChem REST Service Call:
https://www.ebi.ac.uk/unichem/rest/verbose_inchikey/RGLRXNKKBLIBQS-XNHQSDQCSA-N spacer
spacer